AU3039492A - The use of n'-substituted n-phenylsulphonylureas in the treatment of hypertension in insulin-resistant subjects - Google Patents
The use of n'-substituted n-phenylsulphonylureas in the treatment of hypertension in insulin-resistant subjectsInfo
- Publication number
- AU3039492A AU3039492A AU30394/92A AU3039492A AU3039492A AU 3039492 A AU3039492 A AU 3039492A AU 30394/92 A AU30394/92 A AU 30394/92A AU 3039492 A AU3039492 A AU 3039492A AU 3039492 A AU3039492 A AU 3039492A
- Authority
- AU
- Australia
- Prior art keywords
- phenylsulphonylureas
- hypertension
- insulin
- substituted
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 206010020772 Hypertension Diseases 0.000 title 1
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9116093A FR2685326B1 (en) | 1991-12-24 | 1991-12-24 | USE OF N-PHENYLSULFONYL NON-SUBSTITUTED UREAS IN THE TREATMENT OF HYPERTENSION IN INSULIN RESISTANT SUBJECTS. |
| FR9116093 | 1991-12-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3039492A true AU3039492A (en) | 1993-07-01 |
Family
ID=9420459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU30394/92A Abandoned AU3039492A (en) | 1991-12-24 | 1992-12-23 | The use of n'-substituted n-phenylsulphonylureas in the treatment of hypertension in insulin-resistant subjects |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0549433A1 (en) |
| JP (1) | JPH07103032B2 (en) |
| AU (1) | AU3039492A (en) |
| CA (1) | CA2086160A1 (en) |
| FR (1) | FR2685326B1 (en) |
| ZA (1) | ZA9210003B (en) |
-
1991
- 1991-12-24 FR FR9116093A patent/FR2685326B1/en not_active Expired - Fee Related
-
1992
- 1992-12-21 EP EP92403466A patent/EP0549433A1/en not_active Withdrawn
- 1992-12-23 ZA ZA9210003A patent/ZA9210003B/en unknown
- 1992-12-23 CA CA002086160A patent/CA2086160A1/en not_active Abandoned
- 1992-12-23 AU AU30394/92A patent/AU3039492A/en not_active Abandoned
- 1992-12-24 JP JP4344750A patent/JPH07103032B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0549433A1 (en) | 1993-06-30 |
| JPH07103032B2 (en) | 1995-11-08 |
| FR2685326A1 (en) | 1993-06-25 |
| ZA9210003B (en) | 1994-01-13 |
| FR2685326B1 (en) | 1995-03-03 |
| CA2086160A1 (en) | 1993-06-25 |
| JPH05271189A (en) | 1993-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0441119A3 (en) | The use of l-arginine in the treatment of hypertension and other vascular disorders | |
| HUP0100069A3 (en) | 4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders | |
| AU2326892A (en) | Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use | |
| IL111526A0 (en) | 7H-imidazo (1,2-a) pyrazin-8-one derivatives and their preparation and use | |
| OA09736A (en) | "Human interleukin-3 and muteins thereof". | |
| AU2466695A (en) | The use of famotidine and related compounds in the treatment of movement disorders | |
| AU5590696A (en) | Use of quinones in the treatment of cancer or AIDS | |
| EP0736600A3 (en) | Use of an "immunodeficiency-virus suppressing lymphokine (ISL)" to inhibit the replication of viruses, in particular of retroviruses | |
| AU7384094A (en) | Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders | |
| ZA926189B (en) | Beta-Phenylisoserine derivatives and their preparation and use. | |
| DE3567211D1 (en) | (pyrrol-1-yl)-phenyl-dihydropyridazinones, their preparation and use | |
| AU2992492A (en) | The use of d-fenfluramine and fenfluramine compounds in the treatment of hypertension in insulin-resistant subjects | |
| EP0437026A3 (en) | Use of tandospirone in the treatment of depression | |
| ZA935154B (en) | Use of 1,2,5-oxadiazole-2-oxides for the treatment of erectile dysfunctions | |
| ZA932576B (en) | 1,2,4-benzothiadiazine-3-carboxylic acid derivatives, their preparation and their use | |
| AU587646B2 (en) | 5-aryl-2,4-dialkyl-3H-1,2,4-triazole-3-thiones and their use as antidepressants | |
| AU1106392A (en) | Composition and use | |
| AU3070192A (en) | Uses of 1,1,1,3,3,3-hexafluoropropane | |
| AU1850092A (en) | 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents | |
| AU3039492A (en) | The use of n'-substituted n-phenylsulphonylureas in the treatment of hypertension in insulin-resistant subjects | |
| AU6736096A (en) | 1(hetero)aryl-4-(condensed thiazol-2-ylalkyl)-piperazine derivatives, their preparation and their use in the treatment of 5-ht1a-receptor mediated disorders | |
| AU1219092A (en) | Substituted 2', 3'-dideoxy-5-trifluoromethyluridines, processes for their preparation and their use in medicaments | |
| AU4096789A (en) | The use of lactam derivatives in the treatment of cognitive disorders | |
| AU5975094A (en) | 1,2,4-triazinone derivatives and their use in therapy | |
| AU3084992A (en) | 1,4-dihydropyridines for use in the treatment of dermatosis |